COVID-19 company update
Statement from the CEO
Zigzag is adapting to meet the challenges of the current COVID-19 outbreak.
The health and well-being of employees, clients and site personnel, are of upmost importance and central to our core values. We continue to closely monitor the progress of the COVID-19 outbreak and the impact it is having on clinical trials, particularly with the QA aspect.
Zigzag is committed to providing companies with QA expertise and guidance to support you through these unprecedented times.
We are here and ready to help you.